Last reviewed · How we verify
NCT05441605
Effect of Chlorhexidine Solution in Preventing Peripheral Venous Catheter Associated-Infection
NA trial testing Effects of Chlorhexidine Solutions with Different Concentrations in Preventing Peripheral Venous Catheter-Associated Infections in Catheter-Associated Infections in 96 participants. Completed in 14 July 2023.
1 April 2023
Quick facts
| Lead sponsor | Aydin Adnan Menderes University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 96 |
| Start date | 24 June 2022 |
| Primary completion | 1 April 2023 |
| Estimated completion | 14 July 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Effects of Chlorhexidine Solutions with Different Concentrations in Preventing Peripheral Venous Catheter-Associated Infections
Conditions studied
- Catheter-Associated Infections — all drugs for Catheter-Associated Infections →
Sponsor
Aydin Adnan Menderes University
Who can join
18 and older, any sex, with Catheter-Associated Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research aims to determine the most effective chlorhexidine concentration to be used in preventing peripheral venous catheter-associated infections. This research is a randomized controlled double-blinded experimental design. This research will conduct between July 2022-June 2023 with 96 intensive care patients at a state hospital in Turkey. The study sample consist of 96 new insertions of peripheral venous catheters.The study will carried out as a experimental trial to compare the efficacy 1%, 2% and 4% clorhexidine gluconate and 70% alcohol in preventing infections due to catheter administrations in patients. Patients who fulfilled the inclusion criteria is randomized according to the randomization programme into three experimental groups and the control group. "Patient Information Form", "Catheter Information Form" and "Observational Form" will used to collect data.The vital findings and local infection findings of the patients that peripheral venous catheter is inserted will followed and recorded at pre-insertion and once every 24 hours for 96 hours. Culture analyze will performed from swab example taken from catheter entry location at pre-insertion,1st hour and pre removal of catheter.Data will analyzed in statistical program and p\<0,05 will considered as significant.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05441605
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Aydin Adnan Menderes University trials
Trials by the same sponsor.
- NCT07535151 — The Study Aims to Determine the Effect of Using Animal-shaped Magic Mirrors During Vaccination in Children Aged 1-4 Year · not yet recruiting
- NCT07448246 — Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery · NA · recruiting
- NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
- NCT07121699 — The Role of Left Ventricular Outflow Tract (LVOT) Velocity-time Integral (VTI) and Respiratory Variability at Peak Rate · not yet recruiting
- NCT07044739 — Information on the Use of Anti-embolic Stockings in Patients Undergoing Vein Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05441605 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aydin Adnan Menderes University
- Last refreshed: 31 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05441605.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing